↓ Skip to main content

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study

Overview of attention for article published in BMC Cancer, January 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study
Published in
BMC Cancer, January 2022
DOI 10.1186/s12885-021-09128-1
Pubmed ID
Authors

Yukinori Ozaki, Yosuke Aoyama, Jun Masuda, Lina Inagaki, Saori Kawai, Tomoko Shibayama, Tetsuyo Maeda, Mami Kurata, Kazuyo Yoshida, Sumito Saeki, Mari Hosonaga, Ippei Fukada, Fumikata Hara, Takayuki Kobayashi, Kokoro Kobayashi, Satoshi Miyake, Toshimi Takano, Takayuki Ueno, Shinji Ohno

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 16%
Student > Postgraduate 2 11%
Student > Bachelor 1 5%
Unspecified 1 5%
Unknown 12 63%
Readers by discipline Count As %
Medicine and Dentistry 2 11%
Economics, Econometrics and Finance 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Chemistry 1 5%
Social Sciences 1 5%
Other 0 0%
Unknown 13 68%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2022.
All research outputs
#20,944,189
of 23,577,654 outputs
Outputs from BMC Cancer
#6,664
of 8,530 outputs
Outputs of similar age
#421,190
of 513,454 outputs
Outputs of similar age from BMC Cancer
#141
of 223 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,530 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,454 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 223 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.